How GLP-1’s moved from research labs to national TV
Today is the inaugural publishing day for Adam’s Biotech Scorecard — a subscriber-only newsletter offering…
Category: Business
Brazil’s plan for low-cost CAR-Ts
New biotech newsletter launching tomorrow. Don’t miss out. Good morning, everyone. Damian here with the…
STAT+: Steward Health Care has deal to sell doctor network to UnitedHealth
Troubled hospital operator Steward Health Care, grappling with a financial crisis that’s engulfed its eight…
Merck’s next big thing is (probably) on the way
New biotech newsletter launching this Thursday. Don’t miss out. Hello, everyone. Damian here with a look…
EU adviser says Illumina merger was not problematic
Want to stay on top of the science and politics driving biotech today? Sign up to get…
BioNTech is having its Pfizer moment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novo is building a really big computer
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: UnitedHealth appears to be upping loan offers to providers, after Change cyberattack
UnitedHealth Group appears to be offering some providers more substantial loans in the wake of…
Wegovy and Zepbound get primetime treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Contineum Therapeutics files for IPO
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: As AI marches into medicine, investors eye security, privacy startups
Investors are starting to back startups that offer privacy and security services to bolster health…
STAT+: As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’
The biggest enticement that large pharmacy benefit managers offer to the employers that hire them…
What happens when an approved drug doesn’t work?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
Is CAR-T safe for early-stage patients?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Geron’s resurgence might have been short-lived
Want to stay on top of the science and politics driving biotech today? Sign up to get…
When did Wall Street sour on Lilly’s Alzheimer’s drug?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Preventing the weaponization of AI-designed proteins
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: UnitedHealth is on a buying spree of outpatient surgery centers
UnitedHealth Group quietly acquired dozens of outpatient facilities in 2023, with a particular focus on…
STAT+: Medicare announces loan program to aid providers affected by Change cyberattack
Medicare announced on Saturday that it will make advance payments available to physician groups, hospitals,…
STAT+: UnitedHealth gives timeline for Change restoration: payments up by late next week
Change Healthcare’s parent company said it’ll have its electronic payment function up and running by…
Eli Lilly’s anti-vanity ad campaign for Oscars
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Banning WuXi is more complicated than it might sound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Nursing home owners can hide nearly two-thirds of their profits, new study shows
A new study shows that some nursing homes are shunting the majority of their profits…
Bayer’s not breaking up. At least not yet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Oracle Health chair says Cerner isn’t competing with Epic
Cerner may have ceded U.S. business to reigning electronic health records market leader Epic Systems,…
Where’s Lilly’s Alzheimer’s approval?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Serum Institute of India wants government HPV contract
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Medicare is a tricky market for telehealth companies. Why is Talkspace betting on it?
Over the last few years, virtual mental health company Talkspace has been on a relentless…
.jpg)
Despite good data, Ironwood’s shares plummet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The next act for a biotech rainmaker
Want to stay on top of the science and politics driving biotech today? Sign up to…
Beam is trading like it’s 2021
Want to stay on top of the science and politics driving biotech today? Sign up to get…
GSK pill works in uncomplicated gonorrhea
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The FDA isn’t afraid to yank a disappointing drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What do CEOs owe the world?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Stump Pharmalot: An Ask Me Anything with Ed Silverman
In 2023, STAT launched a brand-new home for our subscribers to connect with each other…
Novavax’s money is going in the wrong direction
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Actually Wegovy is good for dialysis companies, dialysis provider says
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Bayer, short on cash, reaches into shareholders’ pockets
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Banning surprise medical bills is raising costs elsewhere
Without question, the new federal law banning surprise billing is achieving its goal of protecting…
Alnylam thickened the plot
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Pharma’s contractors might finally be on the rebound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Replicate’s srRNA rabies vaccine effective in Phase 1
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Private equity investment in Medicare Advantage drops
Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing…
The need to know biotech news stories today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Psychedelic investment continues to ramp up
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: States are ramping up scrutiny of health transactions, as more provider groups look for buyers
UnitedHealth Group’s Optum has bought an untold number of physician practices over the years. It…
STAT+: FTC doubles down in Welsh Carson anesthesia case to limit private equity’s physician buyouts
Lina Khan’s Federal Trade Commission is eager to make Big Physician a lot smaller. Last…
Does Moderna’s RSV vaccine lose efficacy faster than others?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Lasers, cardiology, clinical trials: 2023’s top private equity targets
By some measures, private equity investment lagged in 2023, a year marked by growing distress…
Gilead sours on the ‘don’t eat me’ business
Want to stay on top of the science and politics driving biotech today? Sign up to get…